Cardiac disease and hypothyroidism: Complications induced by initial thyroid therapy

Edward E Wallach, Glenn D. Lubash, Burton D. Cohen, Albert L. Rubin

Research output: Contribution to journalArticle

Abstract

Hypothyroidism was treated with desiccated thyroid substance or a rapid acting preparation in nine patients aged 39 to 84 years. The results are presented in tabular form. The treatment was generally effective, but four patients developed cardiac complications which are described in greater detail. Two patients died. In one patient, a woman 69 years old, it appeared that dosages of thyroid substance sufficient to remedy the myxedema could not be given without danger to the enfeebled heart. Intolerance to thyroid medication was most marked in older patients with a history and physical findings of arteriosclerotic heart disease. By commencing with small doses, two patients were enabled to take larger doses which had previously caused angina pectoris and congestive heart failure. Treatment of hypothyroidism in patients of this type should begin with doses of as little as 7.5 mg. of desiccated thyroid daily, with increments of 7.5 mg. every two or three weeks until a dose of 30 mg. a day is reached.

Original languageEnglish (US)
Pages (from-to)1921-1925
Number of pages5
JournalJournal of the American Medical Association
Volume167
Issue number16
DOIs
StatePublished - Aug 16 1958
Externally publishedYes

Fingerprint

Hypothyroidism
Heart Diseases
Thyroid Gland
Therapeutics
Myxedema
Angina Pectoris
Heart Failure
History

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cardiac disease and hypothyroidism : Complications induced by initial thyroid therapy. / Wallach, Edward E; Lubash, Glenn D.; Cohen, Burton D.; Rubin, Albert L.

In: Journal of the American Medical Association, Vol. 167, No. 16, 16.08.1958, p. 1921-1925.

Research output: Contribution to journalArticle

Wallach, Edward E ; Lubash, Glenn D. ; Cohen, Burton D. ; Rubin, Albert L. / Cardiac disease and hypothyroidism : Complications induced by initial thyroid therapy. In: Journal of the American Medical Association. 1958 ; Vol. 167, No. 16. pp. 1921-1925.
@article{7c6c4b105d7644eba58d657908b0dbb8,
title = "Cardiac disease and hypothyroidism: Complications induced by initial thyroid therapy",
abstract = "Hypothyroidism was treated with desiccated thyroid substance or a rapid acting preparation in nine patients aged 39 to 84 years. The results are presented in tabular form. The treatment was generally effective, but four patients developed cardiac complications which are described in greater detail. Two patients died. In one patient, a woman 69 years old, it appeared that dosages of thyroid substance sufficient to remedy the myxedema could not be given without danger to the enfeebled heart. Intolerance to thyroid medication was most marked in older patients with a history and physical findings of arteriosclerotic heart disease. By commencing with small doses, two patients were enabled to take larger doses which had previously caused angina pectoris and congestive heart failure. Treatment of hypothyroidism in patients of this type should begin with doses of as little as 7.5 mg. of desiccated thyroid daily, with increments of 7.5 mg. every two or three weeks until a dose of 30 mg. a day is reached.",
author = "Wallach, {Edward E} and Lubash, {Glenn D.} and Cohen, {Burton D.} and Rubin, {Albert L.}",
year = "1958",
month = "8",
day = "16",
doi = "10.1001/jama.1958.02990330017005",
language = "English (US)",
volume = "167",
pages = "1921--1925",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "16",

}

TY - JOUR

T1 - Cardiac disease and hypothyroidism

T2 - Complications induced by initial thyroid therapy

AU - Wallach, Edward E

AU - Lubash, Glenn D.

AU - Cohen, Burton D.

AU - Rubin, Albert L.

PY - 1958/8/16

Y1 - 1958/8/16

N2 - Hypothyroidism was treated with desiccated thyroid substance or a rapid acting preparation in nine patients aged 39 to 84 years. The results are presented in tabular form. The treatment was generally effective, but four patients developed cardiac complications which are described in greater detail. Two patients died. In one patient, a woman 69 years old, it appeared that dosages of thyroid substance sufficient to remedy the myxedema could not be given without danger to the enfeebled heart. Intolerance to thyroid medication was most marked in older patients with a history and physical findings of arteriosclerotic heart disease. By commencing with small doses, two patients were enabled to take larger doses which had previously caused angina pectoris and congestive heart failure. Treatment of hypothyroidism in patients of this type should begin with doses of as little as 7.5 mg. of desiccated thyroid daily, with increments of 7.5 mg. every two or three weeks until a dose of 30 mg. a day is reached.

AB - Hypothyroidism was treated with desiccated thyroid substance or a rapid acting preparation in nine patients aged 39 to 84 years. The results are presented in tabular form. The treatment was generally effective, but four patients developed cardiac complications which are described in greater detail. Two patients died. In one patient, a woman 69 years old, it appeared that dosages of thyroid substance sufficient to remedy the myxedema could not be given without danger to the enfeebled heart. Intolerance to thyroid medication was most marked in older patients with a history and physical findings of arteriosclerotic heart disease. By commencing with small doses, two patients were enabled to take larger doses which had previously caused angina pectoris and congestive heart failure. Treatment of hypothyroidism in patients of this type should begin with doses of as little as 7.5 mg. of desiccated thyroid daily, with increments of 7.5 mg. every two or three weeks until a dose of 30 mg. a day is reached.

UR - http://www.scopus.com/inward/record.url?scp=84880372627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880372627&partnerID=8YFLogxK

U2 - 10.1001/jama.1958.02990330017005

DO - 10.1001/jama.1958.02990330017005

M3 - Article

C2 - 13563199

AN - SCOPUS:84880372627

VL - 167

SP - 1921

EP - 1925

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 16

ER -